MODIFICAÇÕES NO CÓDIGO CIVIL REALIZADAS PELA MEDIDA PROVISÓRIA Nº 881/2019 DO GOVERNO FEDERAL

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ECMO or no ECMO: Do no harm.

Extracorporeal membrane oxygenation (ECMO) has been used in the management of neonates with life-threatening cardiorespiratory diseases since 19821. Several studies have demonstrated that ECMO promotes normal survival in neonates with respiratory failure2-4. After decades of discussion, ECMO is now well accepted as a standard of treatment for neonatal respiratory failure refractory to conventio...

متن کامل

Bases Para Um Movimento Pela Inovação Tecnológica No Brasil

Recurrent mistakes in the treatment of technological innovation in Brazil are identified. A movement on behalf of technological innovation is proposed, based on: an understanding of what technological innovation is (and is not); appreciation of every relevant component; recognition of its systemic and self-coordinating character; and the establishment of an appropriate support.

متن کامل

First, do no harm

Conservation agencies charged with care of threatened plant species should be governed by the concepts that conservation actions should do no harm. Adaptive management research progresses in imperfect situations due to incomplete knowledge. Interpreting new experimental or observational evidence for inclusion in conservation plans should first consider the big picture by identifying collateral ...

متن کامل

First, do no harm.

Accessible online at: www.karger.com/onk Fax +49 761 4 52 07 14 [email protected] www.karger.com vational study, Pinder et al. report a 26% increased risk of CHF in older women treated with adjuvant anthracyclines for breast cancer, compared with non-anthracycline regimens [8]. Cardiac troponins are regulatory proteins that control the calcium-mediated interaction of actin and myosin. The t...

متن کامل

First, do no harm.

Early this summer a healthy 62-year-old man with a history of colorectal cancer came to see me for his periodic health examination. In an effort to embrace patient-centred, evidence-informed decision making, much of these visits with healthy men 50 and older in my practice seems to be taken up with discussing the risks and benefits of screening for prostate cancer with a prostate-specific antig...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Percurso

سال: 2019

ISSN: 2316-7521

DOI: 10.21902/revpercurso.2316-7521.v4i31.3707